Security readout for executives and security teams
Plain-English summary
CVE-2018-9332 concerns K7 AntiVirus Premium 15.01.00.53. The public record says an incorrect access control issue can let a local user gain privileges. Available details are sparse, so urgency depends on whether this exact legacy product version exists in your environment.
Executive priority
Handle as a focused endpoint hygiene issue unless asset inventory shows broad deployment. Because the public record lacks severity scoring and fix detail, prioritize confirming exposure first, then follow vendor guidance for any affected systems.
Technical view
The CVE describes a local privilege-gain impact in K7Computing K7AntiVirus Premium 15.01.00.53 due to incorrect access control. No CVSS score, CWE mapping, exploit details, or confirmed fixed version is provided in the supplied sources.
Likely exposure
Exposure appears limited to systems running K7 AntiVirus Premium 15.01.00.53. The bundle does not identify broader product lines, CPEs, operating systems, or later affected versions.
Exploitation context
The source bundle does not show CISA KEV listing or cited evidence of active exploitation. The described impact requires local access, which usually makes this more relevant after initial endpoint compromise or malicious insider access.
Researcher notes
The record is minimal: product/version and local privilege impact are stated, but CVSS, CWE, CPEs, root cause detail, and fixed builds are absent. Do not expand affected scope beyond K7 AntiVirus Premium 15.01.00.53 without vendor evidence.
Mitigation direction
- Inventory endpoints for K7 AntiVirus Premium 15.01.00.53.
- Review K7's advisory for supported update or remediation guidance.
- Upgrade, remove, or replace affected installations if vendor guidance confirms remediation.
- Limit local interactive access on systems running the affected version.
- Monitor vendor support channels for corrected affected-version and fix details.
Validation and detection
- Check endpoint software inventory for the exact product and version.
- Compare installed builds against the K7 advisory and CVE record.
- Confirm whether affected systems are still supported by K7.
- Review endpoint privilege and local-user exposure on affected hosts.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2018-9332 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- https://support.k7computing.com/index.php?/selfhelp/view-article/Advisory-issued-on-6th-January-2021CVE reference, mitre
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.